Last reviewed · How we verify
NCT02607501: EESIS
European eCLIPS™ Safety, Feasibility and Efficacy Study
NA trial testing Implant eCLIPs in Saccular Aneurysm in 20 participants. Terminated before completion.
31 January 2020
Quick facts
| Lead sponsor | Evasc Medical Systems Corp. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 April 2016 |
| Primary completion | 31 January 2020 |
| Estimated completion | 30 September 2021 |
| Sites | 4 locations across Denmark, Netherlands, Germany |
Drugs / interventions tested
- Implant eCLIPs
Conditions studied
- Saccular Aneurysm — all drugs for Saccular Aneurysm →
- Intracranial Aneurysm — all drugs for Intracranial Aneurysm →
Sponsor
Evasc Medical Systems Corp.
Who can join
19 and older, any sex, with Saccular Aneurysm or Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An open label, prospective, multicentre, single-arm, post marketing study evaluating the safety, technical feasibility, and efficacy of the eCLIPs™ Family of Products for the treatment of bifurcation intracranial aneurysms.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
eCLIPs bifurcation remodeling system for treatment of wide neck bifurcation aneurysms with extremely low dome-to-neck and aspect ratios: a multicenter experience.
De Vries J, Boogaarts HD, Sørensen L, Holtmannspoetter M, et al · · 2021 · cited 20× · PMID 32788388 · DOI 10.1136/neurintsurg-2020-016354 -
Development of New Endovascular Devices for Aneurysm Treatment.
Jia ZY, Shi HB, Miyachi S, Hwang SM, et al · · 2018 · cited 17× · PMID 29402066 · DOI 10.5853/jos.2017.02229 -
Safety and efficacy of the eCLIPs bifurcation remodelling system for the treatment of wide necked bifurcation aneurysms: 1 year results from the European eCLIPs Safety, Feasibility, and Efficacy Study (EESIS).
de Vries J, Aquarius R, Sørensen L, Boogaarts HD, et al · · 2023 · cited 8× · PMID 35393338 · DOI 10.1136/neurintsurg-2021-018460
Verify or expand the search:
- PubMed search for NCT02607501
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Evasc Medical Systems Corp. trials
Trials by the same sponsor.
- NCT04886505 — An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms · NA · withdrawn
- NCT05330897 — French eCLIPs™ Efficacy and Safety Investigation · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02607501 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Evasc Medical Systems Corp.
- Last refreshed: 29 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02607501.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing